Cargando…
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database
Background: The SARS-CoV-2 3CLpro is one of the primary targets for designing new and repurposing known drugs. Methodology: A virtual screening of molecules from the Natural Product Atlas was performed, followed by molecular dynamics simulations of the most potent inhibitor bound to two conformation...
Autores principales: | Novak, Jurica, Rimac, Hrvoje, Kandagalla, Shivananda, Grishina, Maria A, Potemkin, Vladimir A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798421/ https://www.ncbi.nlm.nih.gov/pubmed/33415989 http://dx.doi.org/10.4155/fmc-2020-0248 |
Ejemplares similares
-
Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches
por: Kandagalla, Shivananada, et al.
Publicado: (2022) -
Use of the Complementarity Principle in Docking Procedures:
A New Approach for Evaluating the Correctness of Binding Poses
por: Rimac, Hrvoje, et al.
Publicado: (2021) -
Structural Modifications Introduced by NS2B Cofactor Binding to the NS3 Protease of the Kyasanur Forest Disease Virus
por: Kandagalla, Shivananda, et al.
Publicado: (2023) -
A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
por: Novak, Jurica, et al.
Publicado: (2022) -
The Complementarity Principle—One More Step towards Analytical Docking on the Example of Dihydrofolate Reductase Complexes
por: Potemkin, Vladimir, et al.
Publicado: (2021)